Last Updated : April 17, 2025
Date: May 8, 2025
Time: 1:00 p.m. ET (free online event)
Patient group input is vital to the work we do at Canada’s Drug Agency. For our drug reimbursement reviews, including the patient voice provides valuable information and insight to inform our assessment of the evidence and the deliberations of our expert committees that deliver reimbursement recommendations.
As part of our continuous improvement efforts, we are launching a new initiative that aims to evolve our approaches to patient organization input in our drug reimbursement reviews. Patients and representatives from patient organizations are invited to join Michelle Gibbens (Director, Engagement) on May 8, 2025, for an informational webinar at which you will have the opportunity to:
- hear more about the importance of evolving patient group input at Canada’s Drug Agency
- learn about the newly published deliberative framework
- offer early insights into the project.
This event is for patient organization representatives and individual patients and/or caregivers. Canada’s Drug Agency will approve registration and requests, and individuals will be notified by email if their registration is approved.
Following the webinar, we will open a feedback period for patient organizations. If interested, webinar attendees will have the opportunity to offer feedback in 1 of 2 ways — during future small-group sessions or in writing via an online submission.
Last Updated : April 17, 2025